FDA Investigator Igbinoba
Igbinoba has conducted inspections on 1080 sites in 1 countries as of 09 Feb 2012. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
1080
Last Inspection Date:
09 Feb 2012
Investigator Role:
FDA Investigator (Contractor)
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Igbinoba:
Aaron P Wozniak,
Abdur Rashid,
Adam J Williams,
Alaric C Denton,
Alec D Fabus,
Alphonso A Haupt, III,
Amanda L Evanco,
Anthony S Puckett,
Arie R Dyk,
Arlyss M Jones,
Arthur G Hurst,
Babatunde D Babalola,
Bernadette T Tallman,
Betsy C Galliher,
Billy M Battles,
Brandy D Brown,
Burnell M Henry,
Carlos A Ortiz,
Carol J Blackwood,
CDR Thomas R Berry, PPh,
Cheryl D Barton,
Christina H Owens,
Christine M O'leary,
Christopher C Wilcox,
Cordelia J Brammer,
David P Moorhead,
David Williams,
Davis,
Debra J Tucker,
Dellarese L Herbert,
Derek C Price,
Devaughn Edwards,
Donald L Zink,
Douglas Brogden B,
Edward Deberry,
Ernest H Blackwood,
Gabriel R Mclemore,
Gary E Coleman, Jr, REHS,
Heather Akleimola Hulbert,
Heather M Wheeler,
Hristu B Chepa,
Ingrid A Zambrana,
Jack Wvan Stavern,
Jackie M Douglas,
James P Lewis, Jr,
Janet B Gray,
Jawaid Hamid,
Jessica E Gore,
Jhakeim D Seaberry,
Joe A Odom,
John C Francis,
John D Lloyd,
John E Aghadia,
John Stackman,
Johnson,
Joshua C Schafer,
Karen L Anderson,
Kathryn A Nagy,
Kenny R Robinson,
Keri U Walker,
Kevin Brown,
Kimberly Kroesen,
Laura D Cain,
Lawrence S Newsom,
Lawrence Thomas,
Lesley K Satterwhite,
Mancia R Walker,
Marie F Morin,
Matthew G Brown,
Mcbean,
Myla D Chapman,
Nancy E Fontaine,
Nelson A Rodriguez,
Patricia F Hudson,
Paula J Bretz,
Perry H Gambrell,
Rachael Lucinski,
Randy L Clarida,
Rashard A Knight,
Rashonda N Rucker,
Richard L Garcia,
Robert J Rutherford,
Robert P Neligan,
Robert Q Green,
Robert W Turner,
Robin N Goins,
Rohn R Robertson,
Russell R Zablan,
Sally Gopaul,
Sameerah K Abdur Rashid,
Samuel A Hamblin,
Sandra R Saunders,
Sara Ann R Brown,
Seneca D Toms,
Sharpe,
Sondra L Phillips,
Stardust W Mazzariello,
Stephanie E Hubbard,
Susan O Oladeji,
Theresa L Stewart,
Trang N Cox,
Trent D Lecoultre,
Tyrico K English,
Vincent M Williams,
Weedb,
Young Kim
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more